Evidence map›Paper›PMID 39065614›Full record

ArticlePharmaceutics2024

Determination of

Cecília Alvim Dutra, Raquel Lima de Figueiredo Teixeira, Márcia Quinhones Pires Lopes, Victória de Moraes Silva, Philip Noel Suffys, Ricardo de Souza Carvalho, Adriana Rezende Moreira, Adalberto Rezende Santos, Afrânio Lineu Kritski

Abstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cecília Alvim DutraAcademic Tuberculosis Program, Faculty of Medicine, HUCFF-IDT Hospital Complex, Federal University of Rio de Janeiro, Rio de Janeiro 21941-913, Brazil.
Raquel Lima de Figueiredo TeixeiraLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, IOC/Fiocruz, Avenida Brasil, 4365, Rio de Janeiro 21040-360, Brazil.
Márcia Quinhones Pires LopesLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, IOC/Fiocruz, Avenida Brasil, 4365, Rio de Janeiro 21040-360, Brazil.
Victória de Moraes SilvaLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, IOC/Fiocruz, Avenida Brasil, 4365, Rio de Janeiro 21040-360, Brazil.
Philip Noel SuffysLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, IOC/Fiocruz, Avenida Brasil, 4365, Rio de Janeiro 21040-360, Brazil.
Ricardo de Souza CarvalhoDepartment of General Medicine, University of Rio de Janeiro (UniRio), Rio de Janeiro 20270-330, Brazil.
Adriana Rezende MoreiraAcademic Tuberculosis Program, Faculty of Medicine, HUCFF-IDT Hospital Complex, Federal University of Rio de Janeiro, Rio de Janeiro 21941-913, Brazil.ORCID 0000-0001-7057-805X
Adalberto Rezende SantosLaboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, IOC/Fiocruz, Avenida Brasil, 4365, Rio de Janeiro 21040-360, Brazil.ORCID 0000-0002-9514-4589
Afrânio Lineu KritskiAcademic Tuberculosis Program, Faculty of Medicine, HUCFF-IDT Hospital Complex, Federal University of Rio de Janeiro, Rio de Janeiro 21941-913, Brazil.ORCID 0000-0002-5900-6007

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human N-acetyltransferase 2 enzyme, encoded by the

Indexed as

NAT2pharmacogeneticssingle-nucleotide polymorphismstreatmenttuberculosis

Identifiers

PMID39065614
PMCPMC11279449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.